Canton Strategic Holdings (CNTN) Cash from Financing Activities (2021 - 2026)

Canton Strategic Holdings (CNTN) reported Cash from Financing Activities of $87.0 million for Q1 2026, up 42200.79% on a YoY basis from N/an in Q1 2025, and down 10.76% quarter-over-quarter from $97.4 million in Q4 2025.

Canton Strategic Holdings (CNTN) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Cash from Financing Activities for 6 years, with the latest figure at $87.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 42200.79% year-over-year to $87.0 million; the trailing twelve-month figure through Mar 2026 stood at $193.9 million (up 5579.56% YoY), and the FY2025 full-year result was $107.2 million, up 2939.54% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $87.0 million, down from $97.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $97.4 million in Q4 2025, with the low at -$338585.0 in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $13.1 million across 5 years, with a median of $1.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 485.1% — and 2026, when it surged 42200.79%.
  • Canton Strategic Holdings' Cash from Financing Activities stood at -$193457.0 in 2022, then surged by 5094.25% to $9.7 million in 2023, then slumped by 81.18% to $1.8 million in 2024, then soared by 5257.28% to $97.4 million in 2025, then decreased by 10.76% to $87.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $87.0 million (Q1 2026), $97.4 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - 86.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 86.96 Mn
Mar 31, 2026 86.96 Mn
Dec 31, 2025 97.44 Mn
Dec 31, 2025 97.44 Mn
Sep 30, 2025 7.22 Mn
Sep 30, 2025 7.22 Mn
Jun 30, 2025 2.31 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 205,568.00
Mar 31, 2025 205,568.00
Dec 31, 2024 1.82 Mn
Dec 31, 2024 1.82 Mn
Sep 30, 2024 -257,730.00
Sep 30, 2024 -257,730.00
Jun 30, 2024 1.65 Mn
Jun 30, 2024 1.65 Mn
Mar 31, 2024 317,119.00
Mar 31, 2024 317,119.00
Dec 31, 2023 9.66 Mn
Dec 31, 2023 9.66 Mn